Titan Pharmaceuticals
TTNP
#10331
Rank
โ‚น0.56 B
Marketcap
โ‚น424.43
Share price
-3.76%
Change (1 day)
20.90%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -โ‚น369.19

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น404.17. In 2023 the company made an earnings per share (EPS) of -โ‚น682.22 an increase over its 2022 EPS that were of -โ‚น1,398.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น369.19
2023-โ‚น682.22-51.22%
2022-โ‚น1,398-15.61%
2021-โ‚น1,657-81.37%
2020-โ‚น8,894-77.52%
2019-โ‚น39,570-56.32%
2018-โ‚น90,595-59.51%
2017-โ‚น2,23,769-371.81%
2016โ‚น82,325-144.35%
2015-โ‚น1,85,609300%
2014-โ‚น46,402-121.54%
2013โ‚น2,15,439-151.38%
2012-โ‚น4,19,277-11.54%
2011-โ‚น4,73,965188.89%
2010-โ‚น1,64,065-10%
2009-โ‚น1,82,294
2007-โ‚น7,47,407-2.38%
2006-โ‚น7,65,636-39.13%
2005-โ‚น12,57,831-16.87%
2004-โ‚น15,13,043-22.43%
2003-โ‚น19,50,5494.9%
2002-โ‚น18,59,40261.9%
2001-โ‚น11,48,454-13.7%
2000-โ‚น13,30,74865.01%
1999-โ‚น8,06,478-35.87%
1998-โ‚น12,57,616-1824.71%
1997โ‚น72,918-102.4%
1996-โ‚น30,44,315

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น1,025-353.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น677.61-267.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-โ‚น130.74-67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚น2.76-100.68%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-โ‚น23.02-94.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น311.19-23.01%๐Ÿ‡บ๐Ÿ‡ธ USA